Show simple item record

dc.contributor.authorREID, J
dc.contributor.authorMISKI, MAHMUD
dc.contributor.authorWANG, S
dc.contributor.authorXIE, W
dc.contributor.authorGAUVIN, B
dc.contributor.authorKELLEY, M
dc.contributor.authorSARUP, J
dc.contributor.authorSAWUTZ, DG
dc.contributor.authorDOLLE, RE
dc.contributor.authorFALTYNEK, CR
dc.contributor.authorMILLER, D
dc.date.accessioned2021-03-02T20:53:51Z
dc.date.available2021-03-02T20:53:51Z
dc.date.issued1995
dc.identifier.citationMILLER D., WANG S., REID J., XIE W., GAUVIN B., KELLEY M., SARUP J., SAWUTZ D., MISKI M., DOLLE R., et al., "APPROACH TO THE DISCOVERY OF NOVEL, SELECTIVE INHIBITORS OF P56(LCK) TYROSINE KINASE - IDENTIFICATION OF NON-HYDROXYLATED CHROMONES AS P56(LCK) INHIBITORS", DRUG DEVELOPMENT RESEARCH, cilt.34, sa.4, ss.344-352, 1995
dc.identifier.issn0272-4391
dc.identifier.othervv_1032021
dc.identifier.otherav_0441d4b1-c1a8-4741-9963-5d0bfc78041a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/8796
dc.identifier.urihttps://doi.org/10.1002/ddr.430340406
dc.description.abstractThe protein tyrosine kinase p56(lck), which is expressed predominantly in lymphocytes, plays a critical role in optimal T cell activation through the T cell antigen receptor. An approach is presented for the discovery of selective p56(lck) inhibitors, which are potential immunosuppressants. A non-radioactive assay for p56(lck) tyrosine kinase activity has been developed and adapted for high volume screening. This assay does not require purified enzyme. p56(lck) in the plasma membranes of a human T cell line is purified in situ by immobilization onto the wells of a microtiter plate using an antibody specific for p56(lck). Following the kinase reaction in the presence of test compound, autophosphorylated p56(lck) is detected with a biotinylated monoclonal antibody to phosphotyrosine. Using the approach described in this report, three simple chromones have been identified that inhibit p56(lck) autophosphorylation with low micromolar potencies and exhibit some selectivity fdr p56(lck) over the serine/threonine and other tyrosine kinases tested. These compounds constitute a novel group of p56(lck) tyrosine kinase inhibitors. (C) 1995 Wiley-Liss, Inc.
dc.language.isoeng
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectBiyokimya
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectTemel Bilimler (SCI)
dc.subjectKimya
dc.subjectKİMYA, TIP
dc.titleAPPROACH TO THE DISCOVERY OF NOVEL, SELECTIVE INHIBITORS OF P56(LCK) TYROSINE KINASE - IDENTIFICATION OF NON-HYDROXYLATED CHROMONES AS P56(LCK) INHIBITORS
dc.typeMakale
dc.relation.journalDRUG DEVELOPMENT RESEARCH
dc.contributor.department, ,
dc.identifier.volume34
dc.identifier.issue4
dc.identifier.startpage344
dc.identifier.endpage352
dc.contributor.firstauthorID93830


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record